FloraSeq was founded in Waukesha, WI in 2014 to leverage the knowledge of the human microbiome. The founders are Steve Visuri and Karen Harrington who have over 40 years of experience in medical devices and diagnostics with senior leadership positions at Prodesse, Gen-Probe, and Hologic. Initially we are focused on developing microbiota-based products to treat recurrent clostridium difficile (C. diff) infections. In parallel, we are seeking to establish a CLIA Clinical Laboratory to perform complimentary diagnostic testing. Future opportunities include next-generation therapeutics for treating a variety conditions related to gut dysbiosis and expansion of laboratory test menu.